These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1886 related articles for article (PubMed ID: 25939054)
21. Mendelian randomization as a tool for causal inference in human nutrition and metabolism. Larsson SC Curr Opin Lipidol; 2021 Feb; 32(1):1-8. PubMed ID: 33278081 [TBL] [Abstract][Full Text] [Related]
22. Meta-analysis and Mendelian randomization: A review. Bowden J; Holmes MV Res Synth Methods; 2019 Dec; 10(4):486-496. PubMed ID: 30861319 [TBL] [Abstract][Full Text] [Related]
23. Phenome-wide Mendelian-randomization study of genetically determined vitamin D on multiple health outcomes using the UK Biobank study. Meng X; Li X; Timofeeva MN; He Y; Spiliopoulou A; Wei WQ; Gifford A; Wu H; Varley T; Joshi P; Denny JC; Farrington SM; Zgaga L; Dunlop MG; McKeigue P; Campbell H; Theodoratou E Int J Epidemiol; 2019 Oct; 48(5):1425-1434. PubMed ID: 31518429 [TBL] [Abstract][Full Text] [Related]
24. Mendelian Randomization Implicates High-Density Lipoprotein Cholesterol-Associated Mechanisms in Etiology of Age-Related Macular Degeneration. Burgess S; Davey Smith G Ophthalmology; 2017 Aug; 124(8):1165-1174. PubMed ID: 28456421 [TBL] [Abstract][Full Text] [Related]
26. Mendelian randomization in cardiometabolic disease: challenges in evaluating causality. Holmes MV; Ala-Korpela M; Smith GD Nat Rev Cardiol; 2017 Oct; 14(10):577-590. PubMed ID: 28569269 [TBL] [Abstract][Full Text] [Related]
27. Model checking via testing for direct effects in Mendelian Randomization and transcriptome-wide association studies. Deng Y; Pan W PLoS Comput Biol; 2021 Aug; 17(8):e1009266. PubMed ID: 34339418 [TBL] [Abstract][Full Text] [Related]
28. Mendelian Randomization in Cardiovascular Research: Establishing Causality When There Are Unmeasured Confounders. Bell KJL; Loy C; Cust AE; Teixeira-Pinto A Circ Cardiovasc Qual Outcomes; 2021 Jan; 14(1):e005623. PubMed ID: 33397121 [TBL] [Abstract][Full Text] [Related]
29. Using Mendelian randomization to investigate a possible causal relationship between adiposity and increased bone mineral density at different skeletal sites in children. Kemp JP; Sayers A; Smith GD; Tobias JH; Evans DM Int J Epidemiol; 2016 Oct; 45(5):1560-1572. PubMed ID: 27215616 [TBL] [Abstract][Full Text] [Related]
30. Exploring the causal pathway from ischemic stroke to atrial fibrillation: a network Mendelian randomization study. Hou L; Xu M; Yu Y; Sun X; Liu X; Liu L; Li Y; Yuan T; Li W; Li H; Xue F Mol Med; 2020 Jan; 26(1):7. PubMed ID: 31941463 [TBL] [Abstract][Full Text] [Related]
31. An iterative approach to detect pleiotropy and perform Mendelian Randomization analysis using GWAS summary statistics. Zhu X; Li X; Xu R; Wang T Bioinformatics; 2021 Jun; 37(10):1390-1400. PubMed ID: 33226062 [TBL] [Abstract][Full Text] [Related]
32. Social Isolation, Social Interaction, and Alzheimer's Disease: A Mendelian Randomization Study. Shen LX; Yang YX; Kuo K; Li HQ; Chen SD; Chen KL; Dong Q; Tan L; Yu JT J Alzheimers Dis; 2021; 80(2):665-672. PubMed ID: 33579855 [TBL] [Abstract][Full Text] [Related]
33. Mendelian Randomization versus Path Models: Making Causal Inferences in Genetic Epidemiology. Ziegler A; Mwambi H; König IR Hum Hered; 2015; 79(3-4):194-204. PubMed ID: 26201704 [TBL] [Abstract][Full Text] [Related]
34. Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways. Burgess S; Daniel RM; Butterworth AS; Thompson SG; Int J Epidemiol; 2015 Apr; 44(2):484-95. PubMed ID: 25150977 [TBL] [Abstract][Full Text] [Related]
35. Adiponectin affects estimated glomerular filtration rate: A two-sample bidirectional Mendelian randomization study. Bai Y; Chen Z; Wen Z; Long X; Mo Z; Xu J Nephrology (Carlton); 2021 Mar; 26(3):227-233. PubMed ID: 33484075 [TBL] [Abstract][Full Text] [Related]
36. Mendelian randomization studies on atherosclerotic cardiovascular disease: evidence and limitations. Hu Q; Hao P; Liu Q; Dong M; Gong Y; Zhang C; Zhang Y Sci China Life Sci; 2019 Jun; 62(6):758-770. PubMed ID: 31104264 [TBL] [Abstract][Full Text] [Related]
37. Assessing causal relationships using genetic proxies for exposures: an introduction to Mendelian randomization. Katikireddi SV; Green MJ; Taylor AE; Davey Smith G; Munafò MR Addiction; 2018 Apr; 113(4):764-774. PubMed ID: 28921935 [TBL] [Abstract][Full Text] [Related]
38. Improving the accuracy of two-sample summary-data Mendelian randomization: moving beyond the NOME assumption. Bowden J; Del Greco M F; Minelli C; Zhao Q; Lawlor DA; Sheehan NA; Thompson J; Davey Smith G Int J Epidemiol; 2019 Jun; 48(3):728-742. PubMed ID: 30561657 [TBL] [Abstract][Full Text] [Related]
39. Modifiable environmental exposure and risk of rheumatoid arthritis-current evidence from genetic studies. Jiang X; Alfredsson L Arthritis Res Ther; 2020 Jun; 22(1):154. PubMed ID: 32571398 [TBL] [Abstract][Full Text] [Related]
40. [Mendelian randomisation - a genetic approach to an epidemiological method]. Stensrud MJ Tidsskr Nor Laegeforen; 2016 Jun; 136(11):1002-5. PubMed ID: 27325033 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]